Wuxi Pharmatech (Cayman) Inc., of Shanghai, said its wholly owned subsidiary, Syntheall Pharmaceutical Co. Ltd. (STA), received approval from China's National Equities Exchange and Quotations to list its shares on the New Third Board, China's over-the-counter stock exchange, beginning April 3.